Uncertainty Quantification Using Ensemble Learning and Monte Carlo Sampling for Performance Prediction and Monitoring in Cell Culture Processes
0
Sign in to get full access
Overview
- This paper presents a method for quantifying uncertainty in performance predictions and monitoring for cell culture processes.
- The approach combines ensemble learning and Monte Carlo sampling to capture the inherent variability and uncertainty in the system.
- The researchers demonstrate the effectiveness of their method on a case study involving the production of a therapeutic protein in a bioreactor.
Plain English Explanation
The paper focuses on a challenge faced in the production of biological therapies, such as those made in cell culture processes. These processes can be quite complex, with many variables that can affect the final product quality and yield. Uncertainty quantification is crucial in this context, as it allows researchers and engineers to understand the potential range of outcomes and make more informed decisions.
The researchers propose a novel approach that uses ensemble learning and Monte Carlo sampling to quantify the uncertainty in performance predictions and monitoring for cell culture processes. Ensemble learning involves training multiple machine learning models on the same problem and combining their outputs, which can capture a wider range of possible outcomes. Monte Carlo sampling is a technique that generates many random samples to simulate the behavior of a system and understand its variability.
By combining these two methods, the researchers are able to better account for the inherent uncertainty in cell culture processes, such as the natural variability in cell behavior and the impact of environmental factors. This information can then be used to make more informed decisions about process optimization, real-time monitoring, and quality control.
The researchers demonstrate the effectiveness of their approach through a case study involving the production of a therapeutic protein in a bioreactor. The results show that the combined ensemble learning and Monte Carlo sampling method can provide more accurate and reliable predictions of process performance compared to traditional approaches.
Technical Explanation
The paper presents a method for uncertainty quantification in performance prediction and monitoring for cell culture processes, which are used to produce a wide range of biological therapies.
The researchers utilize an ensemble learning approach, where multiple machine learning models (e.g., neural networks, random forests, gradient boosting) are trained on the same problem and their outputs are combined. This allows the method to capture a broader range of possible outcomes and better account for the inherent variability in the system.
To further quantify the uncertainty, the researchers employ Monte Carlo sampling. This involves generating many random samples of the input variables (e.g., cell properties, process conditions) and running the ensemble of machine learning models on each sample. The resulting distribution of outputs provides a detailed understanding of the potential range of process performance.
The researchers demonstrate their approach on a case study involving the production of a therapeutic protein in a bioreactor. They show that the combined ensemble learning and Monte Carlo sampling method can provide more accurate and reliable predictions of process performance compared to traditional approaches, such as using a single machine learning model or deterministic simulations.
Critical Analysis
The paper presents a robust and well-designed approach for uncertainty quantification in cell culture processes, which is a crucial aspect of process optimization and control in the biopharmaceutical industry.
One strength of the study is the use of ensemble learning, which can capture a wider range of possible outcomes than a single model. The authors also carefully validate their approach using experimental data, demonstrating its effectiveness in a real-world case study.
However, the paper does not discuss the computational cost and runtime of the proposed method, which could be a practical concern, especially for large-scale processes or real-time monitoring applications. Additionally, the authors acknowledge that the method relies on the availability of high-quality experimental data for model training, which may not always be the case in practice.
Further research could explore ways to reduce the computational burden, such as through the use of surrogate modeling or adaptive sampling techniques. The authors could also investigate the robustness of their approach to data quality and availability, as well as its applicability to a broader range of cell culture processes and bioprocessing applications.
Conclusion
This paper presents a novel approach for quantifying uncertainty in performance predictions and monitoring for cell culture processes, which is a critical challenge in the production of biological therapies. By combining ensemble learning and Monte Carlo sampling, the researchers are able to better capture the inherent variability and uncertainty in these complex systems.
The demonstrated case study highlights the effectiveness of the proposed method in providing more accurate and reliable predictions, which can inform decision-making and process optimization. While the approach has some practical limitations, it represents an important step forward in addressing the challenges of uncertainty quantification in the biopharmaceutical industry.
This summary was produced with help from an AI and may contain inaccuracies - check out the links to read the original source documents!
Related Papers
0
Uncertainty Quantification Using Ensemble Learning and Monte Carlo Sampling for Performance Prediction and Monitoring in Cell Culture Processes
Thanh Tung Khuat, Robert Bassett, Ellen Otte, Bogdan Gabrys
Biopharmaceutical products, particularly monoclonal antibodies (mAbs), have gained prominence in the pharmaceutical market due to their high specificity and efficacy. As these products are projected to constitute a substantial portion of global pharmaceutical sales, the application of machine learning models in mAb development and manufacturing is gaining momentum. This paper addresses the critical need for uncertainty quantification in machine learning predictions, particularly in scenarios with limited training data. Leveraging ensemble learning and Monte Carlo simulations, our proposed method generates additional input samples to enhance the robustness of the model in small training datasets. We evaluate the efficacy of our approach through two case studies: predicting antibody concentrations in advance and real-time monitoring of glucose concentrations during bioreactor runs using Raman spectra data. Our findings demonstrate the effectiveness of the proposed method in estimating the uncertainty levels associated with process performance predictions and facilitating real-time decision-making in biopharmaceutical manufacturing. This contribution not only introduces a novel approach for uncertainty quantification but also provides insights into overcoming challenges posed by small training datasets in bioprocess development. The evaluation demonstrates the effectiveness of our method in addressing key challenges related to uncertainty estimation within upstream cell cultivation, illustrating its potential impact on enhancing process control and product quality in the dynamic field of biopharmaceuticals.
Read more9/5/2024
0
Uncertainty Quantification in Alzheimer's Disease Progression Modeling
Wael Mobeirek, Shirley Mao
With the increasing number of patients diagnosed with Alzheimer's Disease, prognosis models have the potential to aid in early disease detection. However, current approaches raise dependability concerns as they do not account for uncertainty. In this work, we compare the performance of Monte Carlo Dropout, Variational Inference, Markov Chain Monte Carlo, and Ensemble Learning trained on 512 patients to predict 4-year cognitive score trajectories with confidence bounds. We show that MC Dropout and MCMC are able to produce well-calibrated, and accurate predictions under noisy training data.
Read more8/28/2024
0
Uncertainty Quantification on Clinical Trial Outcome Prediction
Tianyi Chen, Yingzhou Lu, Nan Hao, Capucine Van Rechem, Jintai Chen, Tianfan Fu
The importance of uncertainty quantification is increasingly recognized in the diverse field of machine learning. Accurately assessing model prediction uncertainty can help provide deeper understanding and confidence for researchers and practitioners. This is especially critical in medical diagnosis and drug discovery areas, where reliable predictions directly impact research quality and patient health. In this paper, we proposed incorporating uncertainty quantification into clinical trial outcome predictions. Our main goal is to enhance the model's ability to discern nuanced differences, thereby significantly improving its overall performance. We have adopted a selective classification approach to fulfill our objective, integrating it seamlessly with the Hierarchical Interaction Network (HINT), which is at the forefront of clinical trial prediction modeling. Selective classification, encompassing a spectrum of methods for uncertainty quantification, empowers the model to withhold decision-making in the face of samples marked by ambiguity or low confidence, thereby amplifying the accuracy of predictions for the instances it chooses to classify. A series of comprehensive experiments demonstrate that incorporating selective classification into clinical trial predictions markedly enhances the model's performance, as evidenced by significant upticks in pivotal metrics such as PR-AUC, F1, ROC-AUC, and overall accuracy. Specifically, the proposed method achieved 32.37%, 21.43%, and 13.27% relative improvement on PR-AUC over the base model (HINT) in phase I, II, and III trial outcome prediction, respectively. When predicting phase III, our method reaches 0.9022 PR-AUC scores. These findings illustrate the robustness and prospective utility of this strategy within the area of clinical trial predictions, potentially setting a new benchmark in the field.
Read more6/19/2024
🏅
0
Predicting Safety Misbehaviours in Autonomous Driving Systems using Uncertainty Quantification
Ruben Grewal, Paolo Tonella, Andrea Stocco
The automated real-time recognition of unexpected situations plays a crucial role in the safety of autonomous vehicles, especially in unsupported and unpredictable scenarios. This paper evaluates different Bayesian uncertainty quantification methods from the deep learning domain for the anticipatory testing of safety-critical misbehaviours during system-level simulation-based testing. Specifically, we compute uncertainty scores as the vehicle executes, following the intuition that high uncertainty scores are indicative of unsupported runtime conditions that can be used to distinguish safe from failure-inducing driving behaviors. In our study, we conducted an evaluation of the effectiveness and computational overhead associated with two Bayesian uncertainty quantification methods, namely MC- Dropout and Deep Ensembles, for misbehaviour avoidance. Overall, for three benchmarks from the Udacity simulator comprising both out-of-distribution and unsafe conditions introduced via mutation testing, both methods successfully detected a high number of out-of-bounds episodes providing early warnings several seconds in advance, outperforming two state-of-the-art misbehaviour prediction methods based on autoencoders and attention maps in terms of effectiveness and efficiency. Notably, Deep Ensembles detected most misbehaviours without any false alarms and did so even when employing a relatively small number of models, making them computationally feasible for real-time detection. Our findings suggest that incorporating uncertainty quantification methods is a viable approach for building fail-safe mechanisms in deep neural network-based autonomous vehicles.
Read more4/30/2024